Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (7937)	5/7/2000 1:47:00 PM
From: Spekulatius	Read Replies (1) \| Respond to of 9719

Thanks for the compliment - I am shareholder of Biochem since March and just received the annual report.Reading an annual report sometimes helps to keep things in perspective in these fast internet times. Regarding the VD portfolio stocks, Celgene appears very expensive and overweighted,IMHO. From the non-VD stocks, I think that our old buddy LGND looks better and better, since the management seems to be more focused on building shareholder value and more conscious about burn.